Market revenue in 2023 | USD 56.8 million |
Market revenue in 2030 | USD 139.0 million |
Growth rate | 13.6% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits & Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 54.23% in 2023. Horizon Databook has segmented the Japan mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is anticipated to account for a significant share of the Asia Pacific mycoplasma testing market, as it has one of the most developed pharmaceutical and biotechnology sectors in the region. Moreover, the increasing penetration of key players in Japan market is anticipated to support regional growth. Japan has large biopharmaceutical companies, namely Fujifilm, Terumo, & Sysmex Corporation, which are major users of mycoplasma testing.
These key players are adopting organic growth strategies to gain a competitive edge in the market. For instance, in March 2018, Fujifilm acquired the cell culture media businesses of Irvine Scientific and IS Japan to strengthen its product portfolio. Such initiatives are expected to boost the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Japan mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account